title: A preclinical model of hepatocyte gene transfer: the in vivo, in situ perfused rat liver.
abstract: Delivering retroviruses targeted to hepatocytes in vivo involves the injection of retroviruses directly into the portal vein. The aim of this work was to establish a clinically relevant system for retrovirus-mediated gene transfer in a new model of in vivo, in situ perfused rat liver and to study the transgene expression. At 24 h after partial hepatectomy, the liver was completely excluded from the splanchnic circulation using an extracorporeal shunt. Two independent normothermal, oxygenated perfusion systems were used. First, liver perfusion was carried out with a recirculating system (1 h). Culture supernatant containing retroviruses (1.5 x 10(8) ffu/ml, beta-galactosidase gene) was used as perfusate. Then the liver perfusion was maintained for more 30 min in a single liver passage system using culture medium without retroviruses as perfusate. High hepatocyte transduction rates (up to 34.4%) were obtained. PCR analysis showed no provirus in extrahepatic organs. Viral titrations performed simultaneously (inflow and outflow liver lines) showed that after 1 h of perfusion (up to 30 successive liver passages) retroviruses were still detected in the liver outflow perfusate (up to 2.0 x 10(7) ffu/ml). Washing the liver for 30 min dramatically decreased the leakage of retroviruses in the outflow. In order to be of clinical use, the injection of retroviruses targeted to hepatocytes in vivo should be done while the liver is completely excluded from the splanchnic circulation to avoid any extrahepatic retrovirus diffusion.
authors: Laboratoire de Recherche Chirurgicale et de Biologie Hépatiques, CRI INSERM 94-05, Faculté de Médecine Cochin-Port Royal, Université Paris V, France.
authors: J L
authors: JL
authors: De Godoy
authors: R
authors: R
authors: Malafosse
authors: M
authors: M
authors: Fabre
authors: C
authors: C
authors: Mitchell
authors: M
authors: M
authors: Mehtali
authors: D
authors: D
authors: Houssin
authors: O
authors: O
authors: Soubrane
mesh_terms: D000818:Animals; D015870:Gene Expression; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage*; D022781:Hepatocytes / Q000378:metabolism* / Q000821:virology; D008115:Liver Regeneration; D008297:Male; D008659:Metabolic Diseases / Q000628:therapy*; D023421:Models, Animal; D010477:Perfusion; D016133:Polymerase Chain Reaction; D051381:Rats; D011917:Rats, Inbred Lew; D012190:Retroviridae / Q000235:genetics*; D018709:Statistics, Nonparametric; D001616:beta-Galactosidase / Q000235:genetics
chemical_list: D001616:beta-Galactosidase